Reduced Volume and Faster Infusion Rate of Activated Prothrombin Complex Concentrate: A Phase 3b/4 Trial in Adults with Hemophilia A with Inhibitors

Bülent Zülfikar,Johnny Mahlangu, Salim Mohamed Nekkal,Cecil Ross,Noppacharn Uaprasert,Jerzy Windyga,Carmen Escuriola Ettingshausen,Bettina Ploder, Aurelia Lelli,Hanna T. Gazda

TH Open（2024）

引用 0|浏览0

暂无评分

摘要

Background Activated prothrombin complex concentrate (aPCC) is indicated for bleed treatment and prevention in patients with hemophilia with inhibitors. The safety and tolerability of intravenous aPCC at a reduced volume and faster infusion rates were evaluated.

查看译文

关键词

aPCC,safety,treatment burden,hemophilia with inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要